Business Description
Baskhanbiopharma Inc
ISIN : KR7354390007
Compare
Compare
Traded in other countries / regions
354390.Korea IPO Date
2022-07-20Description
Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.24 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.05 | |||||
| Interest Coverage | 43.09 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.89 | |||||
| Beneish M-Score | -2.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10 | |||||
| 3-Year EBITDA Growth Rate | 93.3 | |||||
| 3-Year Book Growth Rate | 7.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.85 | |||||
| 9-Day RSI | 49.52 | |||||
| 14-Day RSI | 48.56 | |||||
| 6-1 Month Momentum % | -41 | |||||
| 12-1 Month Momentum % | -37.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.56 | |||||
| Quick Ratio | 3.43 | |||||
| Cash Ratio | 0.54 | |||||
| Days Inventory | 55.78 | |||||
| Days Sales Outstanding | 113.9 | |||||
| Days Payable | 32.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5 | |||||
| Shareholder Yield % | 1.15 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.14 | |||||
| Operating Margin % | 3.99 | |||||
| Net Margin % | 9.13 | |||||
| FCF Margin % | 2.22 | |||||
| ROE % | 10.67 | |||||
| ROA % | 8.84 | |||||
| ROIC % | 10.04 | |||||
| ROC (Joel Greenblatt) % | 6.28 | |||||
| ROCE % | 4.68 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.09 | |||||
| PE Ratio without NRI | 10.09 | |||||
| PS Ratio | 0.91 | |||||
| PB Ratio | 1.03 | |||||
| Price-to-Tangible-Book | 1.22 | |||||
| Price-to-Free-Cash-Flow | 41.51 | |||||
| Price-to-Operating-Cash-Flow | 18.76 | |||||
| EV-to-EBIT | 20.4 | |||||
| EV-to-EBITDA | 7.76 | |||||
| EV-to-Revenue | 0.86 | |||||
| EV-to-FCF | 33.1 | |||||
| Price-to-Graham-Number | 0.74 | |||||
| Price-to-Net-Current-Asset-Value | 2.58 | |||||
| Earnings Yield (Greenblatt) % | 4.91 | |||||
| FCF Yield % | 2.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Baskhanbiopharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 30,423.119 | ||
| EPS (TTM) (â‚©) | 396 | ||
| Beta | 0 | ||
| Volatility % | 40.69 | ||
| 14-Day RSI | 48.56 | ||
| 14-Day ATR (â‚©) | 203.452753 | ||
| 20-Day SMA (â‚©) | 3984.75 | ||
| 12-1 Month Momentum % | -37.11 | ||
| 52-Week Range (â‚©) | 3400 - 8200 | ||
| Shares Outstanding (Mil) | 7.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Baskhanbiopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Baskhanbiopharma Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Baskhanbiopharma Inc Frequently Asked Questions
What is Baskhanbiopharma Inc(XKRX:354390)'s stock price today?
The current price of XKRX:354390 is â‚©4000.00. The 52 week high of XKRX:354390 is â‚©8200.00 and 52 week low is â‚©3400.00.
When is next earnings date of Baskhanbiopharma Inc(XKRX:354390)?
The next earnings date of Baskhanbiopharma Inc(XKRX:354390) is .
Does Baskhanbiopharma Inc(XKRX:354390) pay dividends? If so, how much?
Baskhanbiopharma Inc(XKRX:354390) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers